Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI106213

The hyperviscosity syndrome: I. In IgG myeloma. The role of protein concentration and molecular shape

Malcolm R. MacKenzie, H. Hugh Fudenberg, and Robert A. O'Reilly

Division of Immunology Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229

Section of Hematology and Immunology, Department of Medicine, University of California School of Medicine, San Francisco, California 94122

Department of Medicine, Santa Clara Valley Medical Center, The Institute of Medical Research of Santa Clara County, San Jose, California 95128

Find articles by MacKenzie, M. in: PubMed | Google Scholar

Division of Immunology Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229

Section of Hematology and Immunology, Department of Medicine, University of California School of Medicine, San Francisco, California 94122

Department of Medicine, Santa Clara Valley Medical Center, The Institute of Medical Research of Santa Clara County, San Jose, California 95128

Find articles by Fudenberg, H. in: PubMed | Google Scholar

Division of Immunology Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229

Section of Hematology and Immunology, Department of Medicine, University of California School of Medicine, San Francisco, California 94122

Department of Medicine, Santa Clara Valley Medical Center, The Institute of Medical Research of Santa Clara County, San Jose, California 95128

Find articles by O'Reilly, R. in: PubMed | Google Scholar

Published January 1, 1970 - More info

Published in Volume 49, Issue 1 on January 1, 1970
J Clin Invest. 1970;49(1):15–20. https://doi.org/10.1172/JCI106213.
© 1970 The American Society for Clinical Investigation
Published January 1, 1970 - Version history
View PDF
Abstract

The hyperviscosity syndrome is an uncommon complication in IgG myeloma. Its occurrence has been ascribed to the presence in the serum of high molecular weight polymers of the IgG proteins. Three patients with IgG myeloma and the clinical hyperviscosity syndrome were investigated, none of whom had IgG polymers in the serum by analytical ultracentrifugation. Relative serum viscosity in these patients ranged from 10 to 17.4 (normal 1.4-1.8). The total serum proteins ranged from 14 to 19 g/100 ml of which 10 to 17 g/100 ml was IgG globulin. Physicochemical studies of two of the isolated myeloma proteins indicated that they were of normal molecular weight (near 158,000 and 162,000). Protein Ca had a normal molecular radius (52.2 A) and configuration, (intrinsic viscosity of 5.5 cc/g, frictional ratio 1.48), but was present in very high concentration in the serum. Protein Pur had an increased molecular radius (58.2 A) and was asymmetrical (intrinsic viscosity 10.2 cc/g, frictional ratio 1.63). These results indicate that the concentration and molecular configuration of the myeloma protein are important determinants of the presence or absence of the hyperviscosity syndrome.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 15
page 15
icon of scanned page 16
page 16
icon of scanned page 17
page 17
icon of scanned page 18
page 18
icon of scanned page 19
page 19
icon of scanned page 20
page 20
Version history
  • Version 1 (January 1, 1970): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts